Home » Newsletters » BioWorld Science

BioWorld Science

April 16, 2013

View Archived Issues

Pfizer develops novel ADCs targeting IL-13RA2

MRX-34 shows promising results in rodent and nonhuman primate models

Genentech presents preliminary safety and pharmacokinetic data for MPDL-3280A

Neuralgene set to begin animal studies of ALS gene therapy

BAY-94-9343 demonstrates clinical activity in patients with solid tumors

Matrix-Bio and Quest Diagnostics sign metabolomic biomarker licensing agreement

Novartis presents new data for their ALK inhibitor LDK-378

Oncos Therapeutics discloses novel cancer vaccines

Acorda Therapeutics reports phase II Ampyra study results in patients with post-stroke deficits

Hypermethylation of the HOXA4 gene as a potential biomarker in CML

FDA sets PDUFA action date for PA-21

New agents for tuberculosis prepared by CSIR

Merck & Co. presents new ROMK blockers for cardiovascular disorders

Phase I study of Mologen's MGN-1404 approved by Paul-Ehrlich Institute

Novel MAbs targeting human GITR prepared by Sanofi

Eli Lilly patents novel antibodies for lipoprotein disorders

Discovery Labs receives correspondence from FDA regarding updated Surfaxin specifications

Asmacure commences phase I/II trial of dry powder for inhalation of lead compound

New HIF-PH inhibitors synthesized by Merck & Co.

NeurOp receives second half of NIH grant for schizophrenia research

Board recommends continuation of enobosarm phase III trials

Merrimack updates progress of phase II HER2-negative breast cancer study

NeuroDerm studies levodopa/carbidopa patch pump in phase IIa study

Santaris and Bristol-Myers Squibb establish strategic alliance

BHR Pharma updates progress of SyNAPSe study in severe traumatic brain injury

Topline results from first pivotal COPD study of fixed-dose aclidinium/formoterol

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...